An interventional study of Endovascular embolization in Pelvic Congestion Syndrome, sponsored by Sohag University. Recruiting at 1 site in Egypt. Open to female participants aged 17 Years to 55 Years. Per ClinicalTrials.gov, last updated 2026-07-29.
Sponsored by Sohag University · Not applicable, Interventional, and Treatment
Pelvic congestion syndrome (PCS) is a common cause of chronic pelvic pain in women and is associated with pelvic venous insufficiency. This prospective interventional study aims to evaluate the safety and clinical effectiveness of endovascular embolization in relieving symptoms and improving quality of life in women diagnosed with PCS
Pelvic congestion syndrome is characterized by chronic pelvic pain resulting from pelvic venous reflux and varicosities. Endovascular embolization has emerged as a minimally invasive treatment with promising clinical outcomes. This prospective interventional study will evaluate the efficacy and safety of endovascular embolization in female patients with clinically suspected and imaging-confirmed PCS. Patients will undergo clinical assessment, imaging evaluation, and endovascular treatment according to standard institutional protocols. Clinical outcomes will be assessed using pain scores and symptom improvement during follow-up, while procedural success, technical outcomes, and complications will also be recorded
Sohag University is the lead sponsor of 1,183 studies on the registry; 612 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Female patients with pelvic congestion syndrome undergoing endovascular embolization of incompetent ovarian and/or pelvic veins
Procedure: Endovascular embolization
Transcatheter embolization of incompetent ovarian and/or pelvic veins using standard embolic materials according to institutional practice to treat pelvic congestion syndrome.
Also known as: Ovarian vein embolization
Improvement in pelvic pain after endovascular embolization
Change in pelvic pain measured using the Visual Analog Scale (VAS, 0-10), comparing baseline with 6-month follow-up. Unit of Measure: VAS score (0-10)
Time frame: 6 months
Technical success of embolization
Percentage of patients with successful catheterization and complete embolization of all incompetent ovarian and/or pelvic veins during the procedure. Unit: Percentage of participants (%)
Time frame: during the procedure
Change in quality of life
Change in quality of life assessed using the Pelvic Venous Clinical Severity Score (PVCSS) or another predefined questionnaire at baseline and 6 months. Unit: Score
Time frame: 6 months
Procedure-related complications
Assessment of major and minor complications according to the Society of Interventional Radiology (SIR) classification.
Time frame: up to 30 days after the procedure
Quality of life improvement
Improvement in patient's quality of life following embolization
Time frame: 6 months
Plan to share: No — There is no plan to share individual participant data
No publications or documents are linked to this record.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Sohag University